It is established that Ca++ seems to have an informational role in many tissues (Rasmussen, 1970; Rasmussen and Goodman, 1975; Berridge, 1975; Rebhun, 1977) and also in the thyroid, as well as cyclic (Means and Dedman, 1980; Wang and Waisman, 1979; Cheung, 1980) . The fact that calmodulin regulates so many physiological processes indicates the possibillity that alteration of the intracellular level of this protein could also be one of the important mechanisms in control of responses mediated through Ca++. In fact, intracellular calmodulin levels are reported to be altered in a variety of conditions, such as fat cell and liver cell in diabetes (Solomon et al., 1979; Smoake and Solomon 1980; Morley et al., 1982) , interferon treated human WISH cell (Bourgeade et al., 1983) and human red and white cells in chronic renal failure (Mooradian et al., 1983) . As do other tissues, human and bovine thyroids contain calmodulin and calmodulin dependent enzymes (Nagasaka and Hidaka 1976; Yagura et al., 1978; Kasai and Field, 1982; Kobayashi et al., 1979) . In Graves' disease thyroid, phosphodiesterase activity, which is supposed to be stimulated by calmodulin, was reported to be significantly increased, as compared to that in normal human thyroid (Nagasaka and Hidaka, 1976) . Therefore, we consider it important to determine the level of this protein in Graves' disease and normal human thyroids by means of spcific radioimmunoassay in the presence of EGTA. Furthermore, localization of calmodulin in normal human thyroid tissue was determined by means of an indirect immunofluorescence microscopy procedure. (Kakiuchi et al., 1978; Wang and Waisman 1979; Means and Dedman 1980; Klee et al., 1980) . Indeed, it was supposed that Ca++/calmodulin was intimately involved in the regulation of cellular activities in the thyroid gland including cyclic nucleotide metabolism (Yagura et al., 1978) . However, the potential significance of the increase in this protein in thyroid is not clear. A previous report has shown that the rise in the total intracellular calmodulin level in a transformed cell led to destability of microtubules and resulted in a significantly reduced number and length of microtubules as compared with those observed in a nontransformed cell (Chafouleas et al., 1981) . Colchicine and other drugs that promote microtubule disassembly enhanced the stimulation of DNA synthesis in a 3T3 cell by EGF (Friedkin et al., 1979; Otto et al., 1979) and the insulin-or serum-stimulated entry of chick embryo cell into the S phase of the cell cycle (Teng et al., 1977) . Recently, it was reported that a rise in the intracellular level of calmodulin was coupled to the Gl-S transition of the cell cycle, and that inhibition of the action of this protein by the anticalmodulin drug N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide (W13) inhibited progression into S phase (Chafouleas et al., 1982) . Thyroid growth stimulating antibodies were recently detected in sera of some patients with Graves' disease which induce the entry of thyroid epithelial cells into S phase (Drexhage et al., 1980) , prior to which the phase intracellular calmodulin level was reported to be elevated (Chafouleas et al., 1982) . It was also reported that the proportion of cells in S phase was larger in Graves' disease thyroid than that in normal human thyroid. It is also interesting that calmodulin levels in Graves' disease thyroids in which the cell type of follicular epithelium is columnar cell predominant, which is supposed to be most stimulated by thyroid growth stimulating immunoglobulin, were significantly higher than those in a flat cell or a cuboidal cell predominant type. Taking the above facts into account, the rise in the total intracellular level of calmodulin might reflect a larger proportion of cells in S phase in thyroid tissue.
It was also reported that a change in the intracellular calmodulin level could influence on cAMP metabolism by regulating adenylate cyclase or phosphodiesterse activity . For example, the total calmodulin levels in liver cells from rats with streptozotocin-induced diabetes were significantly depressed and such changes might play a role in the alteration of cAMP metabolism known to exist in such pathological states (Smoake and Solomon 1980). Since the intracellular cAMP level in Graves' disease thyroid was elevated (Kuzuya et al., 1980) , the higher calmodulin level might also be related to such changes in cAMP metabolism.
Calmodulin was shown to be preferentially located in the apical border of thyroid epithelial cells, as well as actin (Miyagawa , 1982) and myoglobin (Miyoshi , 1983) . The enrichment of calmodulin in the apical border might suggest the involvement of calmodulin in a process of exo-or endocytosis.
